ADARx Pharmaceuticals Seeks Nasdaq Listing, Files for IPO Under ADRX
ADARx Pharmaceuticals has filed to go public on the Nasdaq Global Market using the ticker ADRX. The company, which focuses on small interfering RNA therapeutics, reports a pipeline that includes three clinical-stage programs and two advanced preclinical programs. Leading investment banks have been named as underwriters, while the firm did not revea…